View drug registration information details.
Items | Registration information |
ID | 8 |
No | 8 |
Brand Name | GLYCIKAM SR G2 |
Ingredients | METFORMIN HYDROCHLORIDE BP 500 MG, GLIMEPIRIDE BP 2 MG |
Dosage Form | PROLONGED RELEASE TABLET |
Primary Packaging | ALU-ALU BLISTER |
Storage | STORE BELOW 30 C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | ANTIDIABETE |
Indications | AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETE WHO ARE ALREADY TREATED WITH COMBINATION OF GLIMEPIRID AND METFORMIN OR WHOSE DIABETES IS NOT ADEQUATELY CONTROLLED WITH METFORMIN ALONE. |
Contraindications | RENAL DISEASE AND RENAL DYSDUNCTION, HEPATIC IMPAIRMENT, HYPERSENSITIVITY |
Side Effects | NAUSEA, DIARRHEA, CONSTIPATION, RASH, PRURITUS, HEADACHE, DIZZINESS, LEUKOPENIA |
Unit Price | |
EDL |
No |
Description | ORANGE AND WHITE COLORED, CAPSULE SHAPED, BICONVEX UNCOATED BILAYERED TABLETS HAVING BREAKLINE ON ONE SIDE AND PLAIN ON THE OTHER |
Note | |
License Owner | ASA LAO SOLE COMPANY LIMITED |
Manufacturer | IMPULSE PHARMA PVT. LTD |
Country | INDIA |
Import Registration No | KD641 (FORM 25) |
Import Registration Date | 2022-10-02 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-02-23 |
FDD Registration No | 09 I 5797/24 |
FDD Registration Date | 2024-09-25 |
Expiry Date | 2029-09-24 |
Back to drug list
|